Article
Combination of germline variations associated with survival of folinic acid, fluorouracil and irinotecan-treated metastatic colorectal cancer patients.
Pharmacogenomics - 1 Nov 2019
Labriet Adrien, Lévesque Éric, De Mattia Elena, Cecchin Erika, Jonker Derek, Couture Félix, Simonyan David, Buonadonna Angela, D'Andrea Mario, Villeneuve Lyne, Toffoli Giuseppe, Guillemette Chantal
Abstract excerpt
Aim: Germline variants could modify survival of metastatic colorectal cancer patients (mCRC). Patients & methods: The association of 285 haplotype-tagging SNPs in 11 candidate genes and overall survival (OS) was tested in two cohorts totalizing 417 FOLFIRI-treated mCRC. Gene expression was investigated in vitro and in public datasets. Results: In the combined cohort, CES1 rs9921399T>C was associated with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
